Covidien’s DuraSeal Spine Sealant Receives FDA Approval

The FDA has approved marketing of Covidien’s DuraSeal spine sealant as an adjunct to suturing for intra-operative dural sealing in spine procedures, according to a release from Covidien.

Advertisement

The Mansfield, Mass.-based company says DuraSeal is designed to be a quicker solution than conventional sealing methods for surgeons who are faced with a dural tear.

The FDA approved the same formulation in 2005 for cranial procedures.

Read Covidien’s release on the FDA approval of DuraSeal spine sealant.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.